drugset
drugset / Trial / NCT04654078

Study to Evaluate the Pharmacokinetic Characteristics and Safety of IN-C004 in Healthy Volunteers

NCT04654078 ↗

Phase 1 Completed 48 enrolled HK inno.N Corporation
RandomizedCrossoverOpen-labelTreatment

Summary

To evaluate the pharmacokinetic characteristics and safety of IN-C004 in healthy volunteers

Timeline

Start
2021-01-18
Primary completion
2021-02-05
Completion
2021-02-15

Drugs

EvaluationDrugModalityDoseRoute
Subject IN-C004 Unknown — —
Subject K-CAB Unknown — —

Indications

No indication recorded.